Skip to content

Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19)

Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029735
Enrollment
Unknown
Registered
2020-02-10
Start date
2020-01-26
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

non-severe group and severe gorup:N/A

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: SARI 1. An ARI with history of fever or measured temperature >= 38 degree C and cough; onset within the last ~10 days; and requiring hospitalization. However, the absence of fever does NOT exclude viral infection. 2. Surveillance case definitions for 2019-nCoV: (1) Patients with severe acute respiratory infection (fever, cough, and requiring admission to hospital), AND with no other etiology that fully explains the clinical presentation1 AND at least one of the following: A. a history of travel to or residence in the city of Wuhan, Hubei Province, China in the 14 days prior to symptom onset, or B. patient is a health care worker who has been working in an environment where severe acute respiratory infections of unknown etiology are being cared for. (2) Patients with any acute respiratory illness AND at least one of the following: A. close contact2 with a confirmed or probable case of 2019-nCoV in the 14 days prior to illness onset, or B. visiting or working in a live animal market in Wuhan, Hubei Province, China in the 14 days prior to symptom onset, or C. worked or attended a health care facility in the 14 days prior to onset of symptoms where patients with hospital-associated 2019-nCov infections have been reported.

Exclusion criteria

Exclusion criteria: Researchers believe that patients are not suitable for any other situation in this study.

Design outcomes

Primary

MeasureTime frame
incidence;mortality;

Countries

China

Contacts

Public ContactMin Xie

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

xie_m@126.com+86 18602724678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026